Pacaldo, Riza V.

HRN: 27-39-30  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/08/2025
CEFUROXIME 1.5GM (VIAL)
08/09/2025
08/09/2025
IV
1.5g
Once
For OR
Remove - Pending Acceptance
08/09/2025
CEFUROXIME 1.5GM (VIAL)
08/09/2025
08/10/2025
IV
1.5gm
Q8
S/p Cs
Remove - Pending Acceptance
08/10/2025
CEFUROXIME 500MG (TAB)
08/10/2025
08/16/2025
PO
500mg
Bid
Cs
Remove - Pending Acceptance

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: